NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$26.78 +0.09 (+0.34%)
Closing price 04:00 PM Eastern
Extended Trading
$26.78 +0.00 (+0.02%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$26.62
▼
$26.96
50-Day Range
$13.23
▼
$26.96
52-Week Range
$11.41
▼
$27.23
Volume
1.11 million shs
Average Volume
2.26 million shs
Market Capitalization
$3.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.70
Consensus Rating
Hold

Company Overview

Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties.

The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States.

Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems. The company focuses on providing care in settings designed for surgical procedures outside traditional acute-care hospitals.

AI Generated. May Contain Errors.

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

SGRY MarketRank™: 
1.457733936155 of 5 stars

Surgery Partners scored higher than 29% of companies evaluated by MarketBeat, and ranked 729th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on no strong buy ratings, 2 buy ratings, 9 hold ratings, and 1 sell rating.

  • Downside Risk

    Surgery Partners has a consensus price target of $20.70, representing about 22.8% downside from its current price of $26.82.

  • Amount of Analyst Coverage

    Surgery Partners has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to decrease in the coming year, from $0.14 to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -39.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -39.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.98% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 1.05, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Surgery Partners has recently decreased by 37.54%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • News Sentiment

    Surgery Partners has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Surgery Partners this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for SGRY on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.00% of the stock of Surgery Partners is held by insiders.

  • Percentage Held by Institutions

    Surgery Partners has minimal institutional ownership at this time.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

This is likely to EXPLODE
Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.tc pixel
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY stock has increased by 73.6% and is now trading at $26.8240.

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings data on Monday, November, 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Surgery Partners's quarterly revenue was down .8% compared to the same quarter last year.

Surgery Partners' Board of Directors authorized a share repurchase program on Thursday, February 26th 2026, which authorizes the company to repurchase $200 million in shares, according to EventVestor. This means that the company could repurchase up to 9.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued.

Surgery Partners (SGRY) raised $350 million in an IPO on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share.

Top institutional shareholders of Surgery Partners include State Street Corp (1.72%), BROOKFIELD Corp ON (1.23%), BROOKFIELD Corp ON (1.23%) and Goldman Sachs Group Inc. (0.48%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca.
View institutional ownership trends
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), GE Aerospace (GE), Palantir Technologies (PLTR), Tesla (TSLA) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
11/09/2026
Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
16,000
Year Founded
2004

Price Target and Rating

High Price Target
$25.00
Low Price Target
$14.00
Potential Upside/Downside
-22.7%
Consensus Rating
Hold
Rating Score (0-4)
2.08
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$77.90 million
Net Margins
-2.59%
Pretax Margin
2.66%
Return on Equity
0.98%
Return on Assets
0.38%

Debt

Debt-to-Equity Ratio
1.03
Current Ratio
2.17
Quick Ratio
2.01

Sales & Book Value

Annual Sales
$3.36 billion
Price / Sales
1.04
Cash Flow
$1.70 per share
Price / Cash Flow
15.79
Book Value
$22.16 per share
Price / Book
1.21

Miscellaneous

Outstanding Shares
130,881,000
Free Float
128,263,000
Market Cap
$3.50 billion
Optionable
Optionable
Beta
1.85

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners